Robinson, M., et al., Sustained-released Biodegradable Subconjunctival Implants for Long Term Delivery of Cyclosporin A, Abstract presented at ARVO Annual Meeting, Ft. Lauderdale, Florida, U.S.A., May 9-14, 1999. |
Ross, M., et al., Sustained-release Intraocular Implant for 2-Methoxyestradiol; an Angiostatic Agent for the Treatment of Choroidal Neovascularization, Abstract presented at ARVO Annual Meeting, Ft. Lauderdale, Florida, U.S.A., Apr. 30-May 5, 2000. |
Robinson, M., et al., “Sustained-released Intraocular Implant for Carboxyamide-Amino-Imidizole; a Novel Angiostatic Agent”, Abstract presented at ARVO Annual Meeting, Ft. Lauderdale, Florida, U.S.A., Apr. 30-May 5, 2000. |
Whitcup, S., et al., Sustained-released Methotrexate Implants for the Treatment of Intraocular Lymphoma, Abstract presented at ARVO Annual Meeting, Ft. Lauderdale, Florida, U.S.A., Apr. 30-May 5, 2000. |
King, B., et al., Intraocular Micro-Implants Releasing Triamcinolone Acetonide for Use in Rat Models, Abstract presented at ARVO Annual Meeting, Ft. Lauderdale, Florida, U.S.A., Apr. 30-May 5, 2000. |
Velez, G., et al., Thalidomide Analogue (EM-138) Sustained-release Implants to Treat Choroidal Neovascularization Associated with Macular Degeneration, Abstract presented at ARVO Annual Meeting, Ft. Lauderdale, Florida, U.S.A., Apr. 30-May 5, 2000. |
Jones, L., et al., Acetazolamide Release Rates from Intraocular Lenses, Abstract presented at ARVO Annual Meeting, Ft. Lauderdale, Florida, U.S.A., Apr. 30-May 5, 2000. |